Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fortis Malar HospitalsBOM:523696 +0.51%33 3-Year RORE % is 138.20 as of Jun. 2026. GuruFocus rates BOM:523696 with a GF Score™ of 33/100. Among 597 Healthcare Providers & Services companies, Fortis Malar Hospitals ranks better than 92.96% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Fortis Malar Hospitals's 3-Year RORE % for the quarter that ended in Jun. 2026 was 138.20%.
The industry rank for Fortis Malar Hospitals's 3-Year RORE % or its related term are showing as below:
BOM:523696's 3-Year RORE % is ranked better than 92.96% of 597
companies
in the Healthcare Providers & Services industry
Industry Median: 0.41
vs BOM:523696: 138.20
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Fortis Malar Hospitals 3-Year RORE % Related Terms
Fortis Malar Hospitals 3-Year RORE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:523696 vs HCA, THC, DVA: 3-Year RORE % Comparison
For the Medical Care Facilities subindustry, Fortis Malar Hospitals's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fortis Malar Hospitals 3-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fortis Malar Hospitals's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Fortis Malar Hospitals's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Jun. 2026 and 3-year before.
Fortis Malar Hospitals (BOM:523696) has a 3-Year RORE % of 138.20 as of Jun. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Fortis Malar Hospitals and its competitors. According to the industry distribution chart, Fortis Malar Hospitals ranks #42 out of 597 companies in the Healthcare Providers & Services industry, placing it in the top 7%.
Is Fortis Malar Hospitals' 3-Year RORE % too high?
Fortis Malar Hospitals' current 3-Year RORE % is 138.20. The Healthcare Providers & Services industry median 3-Year RORE % is 0.41. Fortis Malar Hospitals' value of 138.20 is 33607.3% above this industry median. Based on the distribution chart, Fortis Malar Hospitals ranks #42 out of 597 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Fortis Malar Hospitals has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Fortis Malar Hospitals' 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fortis Malar Hospitals ranks #42 out of 597 companies for 3-Year RORE %. This places Fortis Malar Hospitals in the top 7% of its industry — outperforming the majority of peers. The industry median 3-Year RORE % is 0.41. Fortis Malar Hospitals' value of 138.20 is 33607.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.41, based on 597 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fortis Malar Hospitals's current 3-Year RORE % of 138.20 is 33607.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Fortis Malar Hospitals and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fortis Malar Hospitals's current 3-Year RORE % is 138.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortis Malar Hospitals stock overvalued right now?
Fortis Malar Hospitals (BOM:523696) has a current 3-Year RORE % of 138.20. The current 3-Year RORE % is 138.20 and 33607.3% above the Healthcare Providers & Services industry median of 0.41. Fortis Malar Hospitals' overall GF Score™ is 33/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Fortis Malar Hospitals (BOM:523696), the current 3-Year RORE % is 138.20 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Fortis Malar Hospitals Ltd is an India-based company engaged in the provision of healthcare services. It focuses on providing medical care in the areas of cardiology and cardiac surgery, neurosurgery, gynecology, orthopedics, gastroenterology, neurology, pediatrics, diabetes, nephrology, and internal medicine. The company provides healthcare services in various branches of medicine such as general surgery, general medicine, pediatrics, neurology, cardiology, ophthalmology, radiology, pathology, gastroenterology, urology, thoracic surgery, plastic surgery, and other allied specialties. It operates in one business, namely, in the health care services.
33GF Score
Get the complete analysis for BOM:523696
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:523696 has been successfully added to your 
